Mandatory Product Listing: Needed For US VMS Market, Not Mandatory In User Fee Bill

Mandatory Product Listing: Needed For US VMS Market, Not Mandatory In User Fee Bill – CRN

Establishing VMS products MPL as stated within legislation to re-authorize FDA user fee programs for drugs, biologics and medical device applications isn’t urgent enough to prevent passing user fee bill, says CRN chief Steve Mister.

Mandatory product listing for dietary supplements is needed to improve US regulators’ oversight of the industry, says the Council for Responsible Nutrition.

However, imposing an MPL requirement for vitamin, mineral and supplement products as stated in provisions within legislation to re-authorize the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Mandatory Product Listing: Needed For US VMS Market, Not Mandatory In User Fee Bill – CRN

Read the full article – start your free trial today!

More from Regulation

More from Policy & Regulation